Regional Intervention of Stroke Care to Increase Thrombolytic Therapy for Acute Ischemic Stroke

Rahul H. Damani, Samyuktha Anand, Parisa Asgarisabet, Catherine Bissell, Sean Savitz, Jose Suarez

Research output: Contribution to journalArticle

Abstract

Background and Purpose- The aims of this study were to investigate the effect of an intervention to unblind data on r-tPA (recombinant tissue-type plasminogen activator) administration and sharing data with chief executive officers of participating hospitals, on r-tPA administration rates postintervention and on potential healthcare cost savings implemented at 26 Southeast Texas Regional Advisory Council hospitals. Methods- Retrospective analysis of prospective data on thrombolytic therapy from 26 Southeast Texas Regional Advisory Council hospitals, collected between April 2014 and June 2016. The control (blinded) period (Q2-2014 to Q2-2015) was followed by unblinding (Q3-2015). Results- Intervention was associated with 21.1% increase in r-tPA administration rates, with 38.5% increase in r-tPA administration with door-to-needle time ≤60 minutes. An absolute increase in r-tPA administration of 2.1% was seen with an average lifetime cost savings of $3.6 million. Conclusions- Transparent regional data sharing was associated with improved r-tPA administration and healthcare cost savings.

Original languageEnglish (US)
Pages (from-to)2008-2010
Number of pages3
JournalStroke
Volume49
Issue number8
DOIs
StatePublished - Aug 1 2018

Fingerprint

Thrombolytic Therapy
Tissue Plasminogen Activator
Stroke
Cost Savings
Information Dissemination
Health Care Costs
Hospital Chief Executive Officers
Needles

Keywords

  • cost savings
  • hospitals
  • prospective studies
  • retrospective studies
  • stroke, acute
  • thrombolytic therapy

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Cite this

Regional Intervention of Stroke Care to Increase Thrombolytic Therapy for Acute Ischemic Stroke. / Damani, Rahul H.; Anand, Samyuktha; Asgarisabet, Parisa; Bissell, Catherine; Savitz, Sean; Suarez, Jose.

In: Stroke, Vol. 49, No. 8, 01.08.2018, p. 2008-2010.

Research output: Contribution to journalArticle

Damani, Rahul H. ; Anand, Samyuktha ; Asgarisabet, Parisa ; Bissell, Catherine ; Savitz, Sean ; Suarez, Jose. / Regional Intervention of Stroke Care to Increase Thrombolytic Therapy for Acute Ischemic Stroke. In: Stroke. 2018 ; Vol. 49, No. 8. pp. 2008-2010.
@article{8802edf002a24ed6891e90d6624e2714,
title = "Regional Intervention of Stroke Care to Increase Thrombolytic Therapy for Acute Ischemic Stroke",
abstract = "Background and Purpose- The aims of this study were to investigate the effect of an intervention to unblind data on r-tPA (recombinant tissue-type plasminogen activator) administration and sharing data with chief executive officers of participating hospitals, on r-tPA administration rates postintervention and on potential healthcare cost savings implemented at 26 Southeast Texas Regional Advisory Council hospitals. Methods- Retrospective analysis of prospective data on thrombolytic therapy from 26 Southeast Texas Regional Advisory Council hospitals, collected between April 2014 and June 2016. The control (blinded) period (Q2-2014 to Q2-2015) was followed by unblinding (Q3-2015). Results- Intervention was associated with 21.1{\%} increase in r-tPA administration rates, with 38.5{\%} increase in r-tPA administration with door-to-needle time ≤60 minutes. An absolute increase in r-tPA administration of 2.1{\%} was seen with an average lifetime cost savings of $3.6 million. Conclusions- Transparent regional data sharing was associated with improved r-tPA administration and healthcare cost savings.",
keywords = "cost savings, hospitals, prospective studies, retrospective studies, stroke, acute, thrombolytic therapy",
author = "Damani, {Rahul H.} and Samyuktha Anand and Parisa Asgarisabet and Catherine Bissell and Sean Savitz and Jose Suarez",
year = "2018",
month = "8",
day = "1",
doi = "10.1161/STROKEAHA.118.021109",
language = "English (US)",
volume = "49",
pages = "2008--2010",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Regional Intervention of Stroke Care to Increase Thrombolytic Therapy for Acute Ischemic Stroke

AU - Damani, Rahul H.

AU - Anand, Samyuktha

AU - Asgarisabet, Parisa

AU - Bissell, Catherine

AU - Savitz, Sean

AU - Suarez, Jose

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Background and Purpose- The aims of this study were to investigate the effect of an intervention to unblind data on r-tPA (recombinant tissue-type plasminogen activator) administration and sharing data with chief executive officers of participating hospitals, on r-tPA administration rates postintervention and on potential healthcare cost savings implemented at 26 Southeast Texas Regional Advisory Council hospitals. Methods- Retrospective analysis of prospective data on thrombolytic therapy from 26 Southeast Texas Regional Advisory Council hospitals, collected between April 2014 and June 2016. The control (blinded) period (Q2-2014 to Q2-2015) was followed by unblinding (Q3-2015). Results- Intervention was associated with 21.1% increase in r-tPA administration rates, with 38.5% increase in r-tPA administration with door-to-needle time ≤60 minutes. An absolute increase in r-tPA administration of 2.1% was seen with an average lifetime cost savings of $3.6 million. Conclusions- Transparent regional data sharing was associated with improved r-tPA administration and healthcare cost savings.

AB - Background and Purpose- The aims of this study were to investigate the effect of an intervention to unblind data on r-tPA (recombinant tissue-type plasminogen activator) administration and sharing data with chief executive officers of participating hospitals, on r-tPA administration rates postintervention and on potential healthcare cost savings implemented at 26 Southeast Texas Regional Advisory Council hospitals. Methods- Retrospective analysis of prospective data on thrombolytic therapy from 26 Southeast Texas Regional Advisory Council hospitals, collected between April 2014 and June 2016. The control (blinded) period (Q2-2014 to Q2-2015) was followed by unblinding (Q3-2015). Results- Intervention was associated with 21.1% increase in r-tPA administration rates, with 38.5% increase in r-tPA administration with door-to-needle time ≤60 minutes. An absolute increase in r-tPA administration of 2.1% was seen with an average lifetime cost savings of $3.6 million. Conclusions- Transparent regional data sharing was associated with improved r-tPA administration and healthcare cost savings.

KW - cost savings

KW - hospitals

KW - prospective studies

KW - retrospective studies

KW - stroke, acute

KW - thrombolytic therapy

UR - http://www.scopus.com/inward/record.url?scp=85054538025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054538025&partnerID=8YFLogxK

U2 - 10.1161/STROKEAHA.118.021109

DO - 10.1161/STROKEAHA.118.021109

M3 - Article

VL - 49

SP - 2008

EP - 2010

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 8

ER -